Cibc World Markets Corp Harmony Biosciences Holdings, Inc. Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 8,457 shares of HRMY stock, worth $296,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,457Holding current value
$296,248% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$232 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.3 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$45.1 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.07B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...